Rofo 2011; 183(3): 217-225
DOI: 10.1055/s-0029-1245903
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Neuroblastoma Imaging

Bildgebung des NeuroblastomsS. Ley1 , J. Ley-Zaporozhan1 , P. Günther2 , H. E. Deubzer3 , 4 , O. Witt3 , 4 , J.-P. Schenk1
  • 1Department of Diagnostic and Interventional Radiology, Devision of Pediatric Radiology, University Hospital Heidelberg
  • 2Division of Pediatric Surgery, University of Heidelberg
  • 3Childrens Hospital Heidelberg, Department of Pediatric Oncology
  • 4German Cancer Research Center, Clinical Cooperation Unit Pediatric Oncology
Further Information

Publication History

received: 17.4.2010

accepted: 2.11.2010

Publication Date:
17 December 2010 (online)

Zusammenfassung

Das Neuroblastom ist ein embryonaler Tumor des sympathischen Nervensystems und gehört zu den häufigsten soliden Malignomen des Kindesalters. Biologisches Verhalten und klinischer Verlauf weisen eine ausgeprägte Heterogenität auf, die von spontaner Regression bis zu unaufhaltsamer Progression reicht. Diese Übersichtsarbeit erläutert die Risikostratifizierung und therapeutischen Optionen. Eine ausführliche Darstellung der Aufgaben der Bildgebung während des Verlaufs der Erkrankung und typische bildmorphologische Befunde in allen Modalitäten werden dargestellt.

Abstract

Neuroblastoma is an embryonic tumor of the sympathetic nervous system which represents one of the most common malignancies in early childhood. Its clinical and biological behavior show a remarkable heterogeneity, ranging from spontaneous regression to inexorable progression with a fatal outcome. This review summarizes the clinical risk stratification and treatment options. An extensive overview of the role of imaging during the course of the disease and typical imaging findings in all imaging modalities are demonstrated.

References

  • 1 Lonergan G J, Schwab C M, Suarez E S et al. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.  Radiographics. 2002;  22 911-934
  • 2 Berthold F, Simon T. Clinical Presentation of Neuroblastoma. In Cheung N K, Cohn S L, eds Neuroblastoma. New York: Springer; 2005: 63-85
  • 3 Powell J E, Esteve J, Mann J R et al. Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe.  Lancet. 1998;  352 682-687
  • 4 Strenger V, Kerbl R, Dornbusch H J et al. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.  Pediatr Blood Cancer. 2007;  48 504-509
  • 5 Olshan A F. Epidemiology of Neuroblastoma. In: Cheung NK, Cohn SL, eds. Neuroblastoma. New York: Springer; 2005: 1-5
  • 6 Amiel J, Laudier B, Attie-Bitach T et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.  Nat Genet. 2003;  33 459-461
  • 7 Mosse Y P, Laudenslager M, Longo L et al. Identification of ALK as a major familial neuroblastoma predisposition gene.  Nature. 2008;  455 930-935
  • 8 Escobar M A, Grosfeld J L, Powell R L et al. Long-term outcomes in patients with stage IV neuroblastoma.  J Pediatr Surg. 2006;  41 377-381
  • 9 Schweinitz von D, Hero B, Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma.  Eur J Pediatr Surg. 2002;  12 402-409
  • 10 Canete A, Jovani C, Lopez A et al. Surgical treatment for neuroblastoma: complications during 15 years’ experience.  J Pediatr Surg. 1998;  33 1526-1530
  • 11 Gunther P, Troger J, Holland-Cunz S et al. Surgical complications in abdominal tumor surgery in children. Experiences at a single oncological center.  Eur J Pediatr Surg. 2009;  19 297-303
  • 12 Cecchetto G, Mosseri V, De Bernardi B et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group.  J Clin Oncol. 2005;  23 8483-8489
  • 13 Simon T, Hero B, Benz-Bohm G et al. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB 97 trial.  Pediatr Blood Cancer. 2008;  50 965-969
  • 14 Gunther P, Schenk J P, Wunsch R et al. Abdominal tumours in children: 3-D visualisation and surgical planning.  Eur J Pediatr Surg. 2004;  14 316-321
  • 15 Gunther P, Ley S, Troger J et al. 3D Perfusion Mapping and Virtual Surgical Planning in the Treatment of Pediatric Embryonal Abdominal Tumors.  Eur J Pediatr Surg. 2008;  18 7-12
  • 16 Günther P, Göppl M, Tröger J et al. Surgical Planning for solid abdominal tumors in childhood. Analysis of the need and acceptance of computer-assisted 3D-Visualization.  Monatsschr Kinderheilkunde. 2008;  156 569-573
  • 17 Brodeur G M, Pritchard J, Berthold F et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.  J Clin Oncol. 1993;  11 1466-1477
  • 18 Hero B, Simon T, Horz S et al. Metastatic neuroblastoma in infancy: what does the pattern of metastases contribute to prognosis?.  Med Pediatr Oncol. 2000;  35 683-687
  • 19 Simon T, Hero B, Hunneman D H et al. Tumour markers are poor predictors for relapse or progression in neuroblastoma.  Eur J Cancer. 2003;  39 1899-1903
  • 20 Benz-Bohm G, Hero B, Gossmann A et al. Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma How much diagnostic imaging is necessary?.  Eur J Radiol. 2009;  ; Online first
  • 21 Meyer J S, Harty M P, Khademian Z. Imaging of neuroblastoma and Wilms’ tumor.  Magn Reson Imaging Clin N Am. 2002;  10 275-302
  • 22 Schenk J P, Schrader C, Zieger B et al. Referenzradiologie des Nephroblastoms: Diagnosegenauigkeit und Bedeutung für die präoperative Chemotherapie.  Fortschr Röntgenstr. 2006;  178 38-45
  • 23 Hiorns M P, Owens C M. Radiology of neuroblastoma in children.  Eur Radiol. 2001;  11 2071-2081
  • 24 Biasotti S, Garaventa A, Villavecchia G P et al. False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma.  Med Pediatr Oncol. 2000;  35 153-155
  • 25 Goo H W. Whole-body MRI of neuroblastoma.  Eur J Radiol. 2009;  ; online first
  • 26 Uhl M, Altehoefer C, Kontny U et al. MRI-diffusion imaging of neuroblastomas: first results and correlation to histology.  Eur Radiol. 2002;  12 2335-2338
  • 27 Gahr N, Darge K, Hahn G et al. Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma/ganglioneuroma.  Eur J Radiol. 2010;  ; online first
  • 28 Goo H W, Choi S H, Ghim T et al. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.  Pediatr Radiol. 2005;  35 766-773
  • 29 Ley S, Ley-Zaporozhan J, Schenk J P. Whole-body MRI in the pediatric patient.  Eur J Radiol. 2009;  70 442-451
  • 30 Cody D D, Moxley D M, Krugh K T et al. Strategies for formulating appropriate MDCT techniques when imaging the chest, abdomen, and pelvis in pediatric patients.  Am J Roentgenol. 2004;  182 849-859
  • 31 Hammer G P, Seidenbusch M C, Schneider K et al. Inzidenz von Kinderkrebs nach Röntgendiagnostik im Patientenkollektiv der Jahre 1976 – 2003 einer Universitäts-Kinderklinik.  Fortschr Röntgenstr. 2010;  182 404-414

Dr. Sebastian Ley

Diagnostische und Interventionelle Radiologie, Universitätsklinik Heidelberg

Im Neuenheimer Feld 430

69120 Heidelberg

Germany

Phone: ++ 49/62 21/56 84 14

Fax: ++ 49/62 21/56 29 98

Email: sebastian.ley@med.uni-heidelberg.de

    >